MoCRA Adverse Event Reporting: The 15-Day Timeline Explained

What Counts as a Serious Adverse Event?

MoCRA defines a "serious adverse event" as any health-related event associated with the use of a cosmetic product that results in:

• Death
• A life-threatening experience
• Inpatient hospitalization
• A persistent or significant disability or incapacity
• A congenital anomaly or birth defect
• An event requiring medical or surgical intervention to prevent one of the outcomes listed above (based on reasonable medical judgment)

This definition mirrors the serious adverse event standard used for dietary supplements under the Dietary Supplement and Nonprescription Drug Consumer Protection Act. Note that routine skin irritation, temporary redness, or minor allergic reactions that resolve without medical intervention do not typically meet the "serious" threshold — but they should still be documented.

The 15-Business-Day Reporting Timeline

The clock starts when the Responsible Person (or any employee or agent of the Responsible Person) first receives information about a serious adverse event. From that moment, you have exactly 15 business days to submit the report to FDA.

Here is the timeline broken down:

1. Day 0 — Receipt: You (or an employee, contractor, distributor, or retailer acting on your behalf) receive a report of a serious adverse event from a consumer, healthcare provider, or other source.
2. Days 1–5 — Initial assessment: Verify the report, gather additional details from the reporter, and determine whether the event meets the "serious" threshold. Document your assessment.
3. Days 6–12 — Prepare the report: Complete the FDA MedWatch Form 3500A (or equivalent electronic submission through the FDA Safety Reporting Portal). Include the product name, description of the event, consumer demographics (if available), and any medical records.
4. Days 13–15 — Submit: File the report with FDA. Electronic submission through the Safety Reporting Portal is preferred.

Follow-Up Reports

If you receive new medical information about a previously reported serious adverse event within one year of the initial report, you must submit a follow-up report to FDA. The follow-up report must be filed within 15 business days of receiving the new information.

Follow-up reports should reference the original report and include only the new or updated information. This ensures FDA has a complete picture of the event over time.

Record-Keeping Requirements

MoCRA imposes a six-year record retention requirement for adverse events. This applies to all adverse events, not just serious ones. Your records must include:

• The original adverse event report as received
• Your internal assessment of whether the event was serious
• All correspondence with the reporter
• A copy of any MedWatch report submitted to FDA
• Any follow-up information received
• Internal investigation documentation, including root cause analysis if performed

FDA may request access to these records during an inspection. Maintain records in an organized, accessible manner — whether electronic or paper-based — and ensure they can be produced promptly upon request.

Setting Up an Adverse Event Reporting System

To meet the 15-day deadline consistently, every cosmetics company should have a documented standard operating procedure (SOP) that covers:

• Intake channels: How consumers and healthcare providers can report adverse events (phone, email, website form)
• Triage process: Who reviews incoming reports and how quickly they must be assessed for seriousness
• Escalation procedures: How serious events are escalated to the regulatory affairs team for FDA reporting
• Reporting responsibility: Who is responsible for preparing and submitting the MedWatch form
• Training: Customer service staff, social media teams, and distributors should be trained to recognize and escalate potential adverse events